CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
2 hedge funds and large institutions have $5K invested in Global X China Biotech Innovation ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$190K |
| 2 |
Jane Street
New York
|
-$167K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BBPWM
1
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $3K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$2K | +202 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$190K | -16,484 | Closed |
|
|
4
Jane Street
New York
| – | -$167K | -14,549 | Closed |
|